Alexion reports $165M profit for 2Q

ALEXION PHARMACEUTICALS REPORTED a $165 million profit in the second quarter of 2017. /COURTESY ALEXION
ALEXION PHARMACEUTICALS REPORTED a $165 million profit in the second quarter of 2017. /COURTESY ALEXION
NEW HAVEN, Conn. - Alexion Pharmaceuticals Inc., a company that focuses on developing therapies for patients with devastating and rare diseases, reported a $165 million profit for the second quarter of 2017, a 37.5 percent increase year over year. Net earnings were 73 cents per diluted share. The report said the numbers reflected a benefit…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -